Atlas Trials

The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression

Clinical trial NCT04739865 · COMPLETED

Trial details

NCT number
NCT04739865
Sponsor
COMPASS Pathways
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Treatment Resistant Depression
Start date
2020-08-10
Primary completion
2021-10-14
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.